
COCA-COLA EUROPACIFIC PARTNERS
Trading Update for the First Quarter ended
Q1 performance as expected, reaffirming FY25 guidance
Q1 2025 |
|
Change vs 2024 |
||||||
|
Revenue |
Volume |
Revenue per UC[1],[2],[3] |
|
Volume |
Revenue per UC[1],[2],[3] |
FXN[1],[3] Revenue |
Revenue |
|
|
550m |
|
|
(5.5)% |
4.1% |
(1.6)% |
(1.1)% |
APS |
|
344m |
|
|
39.3% |
(10.9)% |
24.0% |
22.2% |
CCEP |
|
894m |
|
|
7.8% |
(2.5)% |
5.1% |
5.0% |
Q1 2025 (Adjusted comparable)[4] |
|
Change vs 2024 (Adjusted comparable)[4] |
||||||
|
Revenue |
Volume (UC) |
Revenue per UC |
|
Comparable volume* |
Revenue per UC |
FXN revenue |
Revenue |
|
|
550m |
|
|
(2.1)% |
4.1% |
(1.6)% |
(1.1)% |
APS |
|
344m |
|
|
2.1% |
2.1% |
1.0% |
(0.5)% |
CCEP |
|
894m |
|
|
(0.6)% |
3.1% |
(0.8)% |
(0.9)% |
"Performance during the first quarter has been broadly as expected, with volumes reflecting calendar related phasing, including the timing of Easter, resulting in a stronger April. We've continued to grow share ahead of the market, create value for our customers and deliver solid gains in revenue per unit case through revenue and margin growth management.
"We operate in resilient and growing categories, supported by the strength of our relationships with our brand partners and customers across our diverse geographies. We're excited about the rest of the year, and I'm pleased to be reaffirming our full year guidance, with an exciting pipeline of portfolio innovation and planned activation still to come.
"While the global macroeconomic environment is volatile, we remain resilient, with leading market positions and locally driven operations across our 31 markets. Today's interim dividend declaration and the ongoing delivery of share buybacks, demonstrate the strength of our business and our ability to deliver continued shareholder value, with strong cash generation also supporting investment in future growth. We are confident we have the right strategy, done sustainably to deliver on our mid-term growth objectives. And we look forward to sharing more on our exciting future at our capital markets event in
* Comparable volume movements adjust for the impact of selling day movements, with two fewer selling days in Q1'25 versus Q1'24
Q1 HIGHLIGHTS[1,4] |
Volume & revenue
Q1 Reported Rev +5.0%; Q1 Adjusted Comparable[4] -0.8%[3]
• Continue to create value, delivering more revenue growth for retail customers in our key markets than our FMCG peers
• Transactions ahead of volume growth in both
• NARTD YTD value share gains[5] +50bps in-store, +10bps in the Away from Home channel (AFH), -20bps online
• Adjusted comparable volume -0.6%[4],[6] : underlying* -0.2%
• By geography:
-
- APS +2.1%[6] reflecting:
▪
▪
• By channel:
AFH +0.7%[6], Home -1.9%[6]
•
• APS: AFH +0.9%, Home +4.5%
• Adjusted comparable revenue per unit case +3.1%%[2],[3],[4] reflecting positive headline pricing & promotional optimisation, partly offset by geographic mix
•
• APS: +2.1% reflecting headline price increases & promotional optimisation in
•
Dividend
• First half interim dividend per share of
Other
Following the transfer of CCEP's
Sustainability highlights
• Retained inclusion on
• Announced our investment in Avalo, a start-up using pioneering AI technology to reduce the carbon footprint of ingredients used in our products
• Opened new returnable glass bottle line in
REAFFIRMING FY25 GUIDANCE[1,4] |
Outlook for FY25 reflects our current assessment of market conditions. Unless stated otherwise, guidance is on an adjusted comparable[4] & FX-neutral basis.
Revenue: growth of approx.~4%
• Balanced between volume & revenue per unit case
• Two fewer selling days in Q1, one extra in Q4
Cost of sales per UC: comparable growth of ~2%
• Expect broadly flat commodity inflation (hedged at ~90% for FY25)
• Concentrate directly linked to revenue per UC through incidence pricing
Operating profit: growth of ~7%
Comparable effective tax rate: ~26%
CAPEX: ~5% of revenue (incl. leases)
Comparable free cash flow: at least
Dividend payout ratio: ~50%[7] based on comparable EPS
Share buyback:
VOLUMES NOTE - Year on year volume movements are disclosed on a comparable and adjusted comparable basis which (i) assumes the acquisition of
*Underlying volume performance excludes the impact of strategic de-listings.
First Quarter Revenue Performance by Geography[1] |
All values are unaudited and all references to volumes are on a comparable basis for
|
Q1 |
||
|
€ million |
% change |
Fx-neutral % change |
FBN[8] |
1,166 |
(2.2)% |
(2.1)% |
|
686 |
(2.8)% |
(2.8)% |
|
759 |
4.8% |
2.3% |
Iberia[9] |
642 |
(3.9)% |
(3.9)% |
Total |
3,253 |
(1.1)% |
(1.6)% |
|
841 |
(1.5)% |
0.6% |
|
595 |
1.0% |
1.5% |
Total APS[4] |
1,436 |
(0.5)% |
1.0% |
|
|
|
|
Total CCEP[4] |
4,689 |
(0.9)% |
(0.8)% |
FBN
• Mid-single digit volume decline reflecting Easter phasing, de-listing of
• Strong Monster performance driven by growth in
• Sprite & Powerade outperformed with double-digit volume growth.
• Revenue/UC[10] growth driven by headline price increases across the markets.
• Mid-single digit volume decline reflecting Easter phasing & more promotional environment.
• Revenue/UC[10] growth driven by annualisation of the headline price increase implemented in Q3 last year.
• Positive pack & brand mix also contributed driven by growth in small packs, Monster & Fuze Tea.
• Mid-single digit volume increase supported by innovation (e.g. Monster
• Revenue/UC[10] growth driven by annualisation of the headline price increase implemented at the end of Q2 last year.
• Growth of Monster,
Iberia
• Slight volume decline driven by
• The portfolio transition from Nestea to Fuze Tea is progressing well.
• Revenue/UC[10] growth driven by headline price increase.
• Volumes broadly flat with growth in the Pacific Islands offsetting slight decline in
• Double-digit growth in Monster & Fanta supported by great activation, execution & innovation including Monster Ultra
• Revenue/UC[10] growth driven largely by headline price increases, promotional optimisation & the pack mix benefit from the growth of mini cans in
• Further share gains & volume growth in
• Volume decline in
• Revenue/UC[10] growth predominantly driven by headline price increases in
First Quarter Volume Performance by Category[1],[4],[6] |
All values are unaudited & all references to volumes are on an adjusted comparable basis. All changes are versus prior year equivalent period unless stated otherwise.
|
Q1 |
|
|
% of Total |
% Change |
Coca-Cola® |
58.6% |
(0.6)% |
Flavours & Mixers |
22.6% |
(1.3)% |
Water, Sports, RTD Tea & Coffee[13] |
11.4% |
(0.2)% |
Other inc. Energy |
7.4% |
0.5% |
Total |
100.0% |
(0.6)% |
Coca-Cola®
Q1 -0.6%
• Coca-Cola Classic -2.0%, cycling strong comparable (Q1'24 +4.4%), with growth in
• Coca-Cola Zero Sugar +4.0% reflects strong growth in both
Flavours & Mixers
Q1 -1.3%
• Sprite -0.7% with growth in
• Fanta -1.4% with overall performance supported by recent launch of new flavours, such as
• Fantastic activation in GB for limited edition Dr. Pepper Cherry Crush supported double-digit volume increase.
Water, Sports, RTD Tea & Coffee
Q1 -0.2%
• Water +3.5% driven by growth of Wilkins Pure in
• Sports +0.7% supported by good growth of Aquarius in
• RTD Tea & Coffee -9.9% with strong performance of Fuze Tea offset by Frestea decline in
Other inc. Energy
Q1 +0.5% (+9.5% exc. Juices)
• Energy +11.9% with Monster growth across all markets supported by continuing pipeline of innovation e.g.
supported by great activation & execution.
• Juices decline resulting from the strategic de-listing of
• Continuing to develop ARTD offering with recent launch of Bacardi & Coke, Absolut & Sprite Watermelon &
Conference Call |
•
• Replay & transcript will be available at www.cocacolaep.com as soon as possible
Dividend |
• The CCEP Board of Directors declared a first-half interim dividend of
• The interim dividend is payable
• CCEP will pay the interim dividend in euros to holders of shares on Euronext Amsterdam, the
• Other publicly held shares will be converted into an equivalent US dollar amount using exchange rates issued by WM/Reuters taken at
https://ir.cocacolaep.com/shareholder-information-and-tools/dividends
Financial Calendar |
• Capital markets event:
• AGM:
• H1 2025 Results:
• Financial calendar available here: https://ir.cocacolaep.com/financial-calendar/
Contacts |
Investor Relations |
|
|
|
|
|
|
|
|
|||
|
|
|
|
Media Relations |
|
|
|
|
|
About CCEP |
of the world's most loved brands - serving nearly 600 million consumers and helping over 4 million customers across 31 countries grow.
We combine the strength and scale of a large, multi-national business with an expert, local knowledge of the customers we serve and communities we support.
The Company is currently listed on Euronext Amsterdam, NASDAQ,
Exchanges, and a constituent of both the Nasdaq 100 and
For more information about CCEP, please visit www.cocacolaep.com & follow CCEP on LinkedIn @
___________________
1. Refer to 'Note Regarding the Presentation of Adjusted financial information and Alternative Performance Measures' for further details & to 'Supplementary Financial Information' for a reconciliation of reported to adjusted comparable results; Change percentages against prior year equivalent period unless stated otherwise
2. A unit case equals approximately 5.678 litres or 24 8-ounce servings
3. Comparable & FX-neutral
4. Non-IFRS adjusted comparable financial information as if the acquisition of
5. External data sources: Nielsen & IRI Period 2 YTD
6. Reflects selling day shift with 2 fewer selling days in Q1'25 versus Q1'24. Excluding the selling days adjusted volumes were: CCEP -3.9%,
7. Dividends subject to Board approval
8. Includes France,
9. Includes Spain,
10. Revenue per unit case
11. Includes Australia,
12. Includes Philippines &
13. RTD refers to ready to drink
Forward-Looking Statements |
This document contains statements, estimates or projections that constitute "forward-looking statements" concerning the financial condition, performance, results, guidance and outlook, dividends, consequences of mergers, acquisitions, joint ventures, divestitures, , strategy and objectives of
Forward-looking statements are subject to certain risks that could cause actual results to differ materially. Forward-looking statements are based upon various assumptions as well as CCEP's historical experience and present expectations or projections. As a result, undue reliance should not be placed on forward-looking statements, which speak only as of the date on which they are made. Factors that, in CCEP's view, could cause such actual results to differ materially from forward looking statements include, but are not limited to, those set forth in the "Risk Factors" section of CCEP's 2024 Annual Report on Form 20-F filed with the
Due to these risks, CCEP's actual future financial condition, results of operations, and business activities, including its results, dividend payments, capital and leverage ratios, growth, including growth in revenue, cost of sales per unit case and operating profit, free cash flow, market share, tax rate, efficiency savings, achievement of sustainability goals, including net zero emissions and recycling initiatives, capital expenditures, may differ materially from the plans, goals, expectations and guidance set out in forward-looking statements. These risks may also adversely affect CCEP's share price. CCEP does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required under applicable rules, laws and regulations.
Note Regarding the Presentation of Adjusted financial information and Alternative Performance Measures |
Adjusted financial information
Non-IFRS adjusted financial information for selected metrics has been provided in order to illustrate the effects of the acquisition of CCBPI on the results of operations of CCEP and to allow for greater comparability of the results of the combined group between periods. The adjusted financial information has been prepared for illustrative purposes only, and because of its nature addresses a hypothetical situation. It does not intend to represent the results had the acquisition occurred at the dates indicated, or project the results for any future dates or periods. It is based on information and assumptions that CCEP believe are reasonable, including assumptions as at 1 January of the period presented relating to transaction accounting adjustments. No cost savings or synergies were contemplated in these adjustments.
The non-IFRS adjusted financial information has not been prepared in accordance with the requirements of Regulation S-X Article 11 of the US Securities Act of 1933 or any generally accepted accounting standards, may not necessarily be comparable to similarly titled measures employed by other companies and should be considered supplemental to, and not a substitute for, financial information prepared in accordance with generally accepted accounting standards.
The acquisition completed on
Alternative Performance Measures
We use certain alternative performance measures (non-IFRS performance measures) to make financial, operating and planning decisions and to evaluate and report performance. We believe these measures provide useful information to investors and as such, where clearly identified, we have included certain alternative performance measures in this document to allow investors to better analyse our business performance and allow for greater comparability. To do so, we have excluded items affecting the comparability of period-over-period financial performance as described below. The alternative performance measures included herein should be read in conjunction with and do not replace the directly reconcilable IFRS measures.
For purposes of this document, the following terms are defined:
''As reported'' are results extracted from our unaudited consolidated financial statements.
"Adjusted" includes the results of CCEP as if the CCBPI acquisition had occurred at the beginning of the period presented, including acquisition accounting adjustments, accounting policy reclassifications and the impact of debt financing costs in connection with the acquisition.
"Comparable'' is defined as results excluding items impacting comparability, such as restructuring charges. Comparable volume is also adjusted for selling days.
''Adjusted comparable" is defined as adjusted results excluding items impacting comparability, as described above.
''Fx-neutral'' or "FXN" is defined as period results excluding the impact of foreign exchange rate changes. Foreign exchange impact is calculated by recasting current year results at prior year exchange rates.
''Capex'' or "Capital expenditures'' is defined as purchases of property, plant and equipment and capitalised software, plus payments of principal on lease obligations, less proceeds from disposals of property, plant and equipment. Capex is used as a measure to ensure that cash spending on capital investment is in line with the Group's overall strategy for the use of cash.
''Comparable free cash flow'' is defined as net cash flows from operating activities less capital expenditures (as defined above) and net interest payments, adjusted for items that are not reasonably likely to recur within two years, nor have occurred within the prior two years. Comparable free cash flow is used as a measure of the Group's cash generation from operating activities, taking into account investments in property, plant and equipment, non-discretionary lease and net interest payments while excluding the effects of items that are unusual in nature to allow for better period over period comparability. Comparable free cash flow reflects an additional way of viewing our liquidity, which we believe is useful to our investors, and is not intended to represent residual cash flow available for discretionary expenditures.
''Dividend payout ratio'' is defined as dividends as a proportion of comparable profit after tax.
Additionally, within this document, we provide certain forward-looking non-IFRS financial information, which management uses for planning and measuring performance. We are not able to reconcile forward-looking non-IFRS measures to reported measures without unreasonable efforts because it is not possible to predict with a reasonable degree of certainty the actual impact or exact timing of items that may impact comparability throughout year.
Supplemental Financial Information - Revenue - Reported to Adjusted Comparable |
Revenue
Adjusted Revenue CCEP In millions of €, except per case data which is calculated prior to rounding. FX impact calculated by recasting current year results at prior year rates. |
First-Quarter Ended |
||
|
|
% Change |
|
As reported and comparable |
4,689 |
4,465 |
5.0% |
Add: Adjusted revenue impact[1] |
- |
268 |
n/a |
Adjusted Comparable |
4,689 |
4,733 |
(0.9)% |
Adjust: Impact of fx changes |
4 |
n/a |
n/a |
Adjusted Comparable and fx-neutral |
4,693 |
4,733 |
(0.8)% |
|
|
|
|
Adjusted Revenue per unit case |
5.25 |
5.09 |
3.1% |
Adjusted Revenue APS |
|
|
|
As reported and comparable |
1,436 |
1,175 |
22.2% |
Add: Adjusted revenue impact[1] |
- |
268 |
n/a |
Adjusted Comparable |
1,436 |
1,443 |
(0.5)% |
Adjust: Impact of fx changes |
21 |
n/a |
n/a |
Adjusted Comparable and fx-neutral |
1,457 |
1,443 |
1.0% |
|
|
|
|
Adjusted Revenue per unit case |
4.24 |
4.15 |
2.1% |
[1] The adjusted financial information for 2024 reflects the inclusion of
Volume
Adjusted comparable Volume - Selling Day Shift CCEP
In millions of unit cases, prior period volume recast using current year selling days |
First-Quarter Ended |
||
|
|
% Change |
|
Volume |
894 |
829 |
7.8% |
Impact of selling day shift |
- |
(25) |
n/a |
Comparable volume - Selling Day Shift adjusted |
894 |
804 |
11.2% |
Add: Adjusted volume impact[1] |
- |
95 |
n/a |
Adjusted comparable volume |
894 |
899 |
(0.6)% |
Adjusted comparable Volume - Selling Day Shift APS |
|
|
|
Volume |
344 |
247 |
39.3% |
Impact of selling day shift |
- |
(5) |
n/a |
Comparable volume - Selling Day Shift adjusted |
344 |
242 |
42.1% |
Add: Adjusted volume impact[1] |
- |
95 |
n/a |
Adjusted comparable volume |
344 |
337 |
2.1% |
[1] The adjusted volume impact reflects the inclusion of
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the